EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis

Lindsay A Ross, Lisa M Stropp, Jeffrey A Cohen

Neurologic Clinics · 2024-02 · 42 (1) · 165-184

DOI: 10.1016/j.ncl.2023.06.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurologic Clinics, 2024-02. Verfasst von Lindsay A Ross und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mellen Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Multiple Sclerosis Society, Program on Philanthropy and Social Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In aggregate, the available data suggest autologous hematopoietic stem cell transplantation (AHSCT) has potent, durable efficacy to treat relapsing multiple sclerosis (MS). Safety issues and financial costs are significant but largely associated with the procedure itself. AHSCT is a reasonable option for patients with highly active relapsing MS and an inadequate response to the available disease therapies. The key question is where to place AHSCT in the overall relapsing MS algorithm relative to other high-efficacy therapies. Ongoing randomized trials will better characterize the benefit and risk of AHSCT compared with currently available high-efficacy disease therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHematopoietic Stem Cell TransplantationHumansTransplantation, Autologous

Stichwörter der Autor:innen

Clinical trialsImmune reconstitutionMultiple sclerosisStem cell transplantationTherapeutics

Autor:innen und Institutionen

  • Mellen Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
  • Mellen Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address: cohenj@ccf.org.

Förderung

  • National Multiple Sclerosis Society
  • Program on Philanthropy and Social Innovation

Zitieren

APA

Ross, L. A., Stropp, L. M., & Cohen, J. A. (2024). Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis. Neurologic Clinics, 42(1), 165-184. https://doi.org/10.1016/j.ncl.2023.06.002

Vancouver

Ross LA, Stropp LM, Cohen JA. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis. Neurologic Clinics. 2024;42(1):165-184. doi:10.1016/j.ncl.2023.06.002

BibTeX
@article{Ross2024,
  author = {Ross, Lindsay A and Stropp, Lisa M and Cohen, Jeffrey A},
  title = {Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis},
  journal = {Neurologic Clinics},
  year = {2024},
  volume = {42},
  number = {1},
  pages = {165--184},
  doi = {10.1016/j.ncl.2023.06.002}
}
Kostenlos starten →